Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
https://meyka.com/licensehttps://meyka.com/license
AI-powered price forecasts for ADMP stock across different timeframes including weekly, monthly, yearly, and multi-year predictions.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Adamis Pharmaceuticals | ADMP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Stock including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Loan Capital including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.06K in Sales Revenues for its fiscal quarter ending in September of 2023. Data for Adamis Pharmaceuticals | ADMP - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8942910 in Net Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Net Income including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $10 in Interest Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Interest Income including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.85M in Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Debt including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.78M in Trade Creditors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6318210 in EBITDA for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ebitda including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $21.17K in Trade Debtors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Debtors including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $7.55M in Current Assets for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Assets including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 10.1M in Outstanding Shares in April of 2024. Data for Adamis Pharmaceuticals | ADMP - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $12.95M in Current Liabilities for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6427680 in Operating Profit for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Operating Profit including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8335000 in Pre-Tax Profit for its fiscal quarter ending in June of 2022. Data for Adamis Pharmaceuticals | ADMP - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.79M in Cost of Sales for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $15.05K in Ordinary Share Capital for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $0 in Interest Expense on Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last August in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.